Related Experiment Videos
Heterogeneity in human colon cancer
Symposium on Fundamental Cancer Research
|January 1, 1983
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides.
International journal of oncology·2001
Antitumor activity and toxicity of novel nitroheterocyclic phosphoramidates.
Journal of medicinal chemistry·2001
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
Cancer chemotherapy and pharmacology·1994
XB596, a promising bis-naphthalimide anti-cancer agent.
Anti-cancer drugs·1993
The arrangement of immunoglobulin, T cell antigen receptor, and interleukin 2 receptor genes in human lymphoid neoplasms.
Symposium on Fundamental Cancer Research·1986
Interleukin 2-activated cytotoxic lymphocytes in cancer therapy.
Symposium on Fundamental Cancer Research·1986
Genetic sequences that predispose to retinoblastoma and osteosarcoma.
Symposium on Fundamental Cancer Research·1986
The molecular determinants of carcinogenesis.
Symposium on Fundamental Cancer Research·1986
Studies on the mechanism of action of protein kinase C and the isolation of molecular clones encoding the enzyme.
Symposium on Fundamental Cancer Research·1986
Proto-oncogene expression and growth factors during liver regeneration.
Symposium on Fundamental Cancer Research·1986